Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

FDA Grants Priority Review to Potential Liver Cancer Therapy

June 30th 2010

An oral therapy currently utilized in the treatment of advanced kidney cancer may be on the threshold of obtaining a major new indication.

Updates from the Breast Cancer Symposium

June 30th 2010

In 2007, more than 240,000 persons will receive a diagnosis of breast cancer and nearly 41,000 will die from the disease. Although survival rates have shown significant improvement over the past several decades, breast cancer continues to be the second most common cause of cancer death in women.

Highlighting Advances in Lung Cancer

June 30th 2010

Lung cancer is the second most common cancer and the most common cause of cancer-related death in both men and women in the US. At the12th World Conference on Lung Cancer (WCLC), the world%u2019s top lung cancer specialists convened to present and discuss the latest research in this disease. Key themes included accurate targets, new combinations of drugs to reduce toxicity, and strategies to improve outcomes.

Updates from Oncology Meetings

June 30th 2010

Oncology & Biotech News provides updates from major oncology meetings because symposia remain an important means for disseminating new data. This issue, we highlight two important meetings: 2007 Breast Cancer Symposium (in San Francisco) and the World Conference on Lung Cancer (in Korea).

The Academy: November 2007

June 29th 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

Fast Facts: New Cancer Survival Data

June 29th 2010

New data recently published in the Journal of Clinical Oncology has provided a degree of hopeful news to oncologists and their patients, suggesting that progress is being made in the fight against cancer and that a number of trends are pointing toward continued gains.

Reimbursement and Managed Care News for November 2007

June 29th 2010

News articles featured in this issue include: 1) Off-Label Use of Oncology Medications 2) More Work to Do on Breast Cancer Guideline Adoption 3) Multiple Biopsies Are Needed to Diagnose Prostate Cancer, and more

Physicians' Financial News November 2007

June 29th 2010

Physicians' Financial News focuses on newsmaking and/or notable companies in the oncology/biotech sector. In this issue: 1) Pharmion: Oncology-Centered Focus Fuels Continued Pharmion Growth 2) Bristol-Myers Squibb: Treatment-Resistant Breast Cancer Targeted 3) Merger-Mania Poised to Envelop Biotech Sector? and more

Sorafenib (Nexavar) Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe

June 29th 2010

The European Commission has granted marketing authorization to sorafenib (Nexavar) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer.

VTE in Cancer Patients: New Guidelines Define Role of Anticoagulants

June 29th 2010

Blood clots and their complications are a major cause of death in cancer patients, and affect up to 20% of persons with cancer at some point in their treatment.

Clinical Trial Reports: November 2007

June 29th 2010

The Clinical Trials Reported in this issue include: PHASE III: 1) Trastuzumab and Anastrozole Extend Breast Cancer Survival in Patients Who Received Anastrozole Alone Earlier PHASE II: 1) Motexafin for Non%u2013Small Cell Lung Cancer 2) Oral Satraplatin Monotherapy for the Treatment of Metastatic Breast Cancer Shows Little Response, and more

Clinical Abstracts From Overseas: June 29, 2010

June 29th 2010

Articles in this issue include: 1) Italy: Is the Knee Bone Connected to the Lung? 2) Turkey: Gabapentin Helps Opioid Treatment Alleviate Neuropathic Pain 3) China: Is a Blood Test for Early Diagnosis of Liver Cancer Within Reach?, and more

Reports from the European Cancer Conference

June 25th 2010

The 14th annual European Cancer Conference, sponsored by the European Cancer Organisation (ECCO), was held September 23-27 in Barcelona, Spain. The results of numerous major clinical trials were presented, along with an increasing wealth of new preclinical and translational data.

Global Focus

June 25th 2010

In this issue, we present updates from the 14th European Cancer Conference (ECCO), which took place September 23-27 in Barcelona, Spain. This year's meeting provided one of the largest multidisciplinary forums for discussing the entire spectrum of cancer research and management.

March 2008

June 25th 2010

The Academy delivers the latest news on biotech and oncoloy research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

Fast Facts: Skin Cancer and Melanoma

June 25th 2010

A collection of statistics and facts on skin cancer and melanoma

Physicians' Financial News: January 2008

June 25th 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue: 1) Bristol-Myers Squibb: BMS Boasts Bright Oncology Future 2) Infinity Pharmaceuticals and AstraZeneca: Prostate Cancer Partnership Begins to Bear Fruit 3) Genentech: Avastin Shown To Halt Brain Cancer Progress, and more

Reimbursement and Managed Care News for January 2008

June 25th 2010

Topics covered in this issue include: 1) Dosing Patterns and Costs of Erythropoesis-Stimulating Agents in Patients With Cancer 2) New Practice Guideline Updates Treatment of Non-Small Cell Lung Cancer 3) Large Health Insurer Begins Genetic Risk Counseling for Cancer, and more

January 2008 Clinical Trial Reports

June 24th 2010

The Clinical Trials reported in this issue include: PHASE III: 1) Atamestane Plus Toremifene Compared With Letrozole for Advanced Receptor-Positive Breast Cancer Treatment 2) Tamoxifen Superior to Arzoxifene for Locally Advanced or Metastatic Breast Cancer 3) Head and Neck Cancer Treatment With Cisplatin, Fluorouracil, and Docetaxel, and more

Clinical Abstracts From Overseas: June 24, 2010

June 24th 2010

Articles in this issue include: Sweden: What Do Genes Have to Do With Cancer Survival? United Kingdom: 1) New Renal Sarcoma Type Characterized 2) Vinflunine for the Treatment of Malignant Pleural Mesothelioma, and more